bilaterals.org logo
bilaterals.org logo

medicines

India to US: Will not tighten IPR rules beyond TRIPS mandate
21-Oct-2016 Hindu Business Line
India and the US continued to differ on the issue of intellectual property rights (IPR) norms in their bilateral trade and investment policy discussions
Activists fret about RCEP impact
20-Oct-2016 Bangkok Post
Access to affordable medicine and farmers’ control over seeds could be undermined by the Regional Comprehensive Economic Partnership being negotiated between Asean member countries and six other trade partners, says FTA Watch in Thailand
An open letter to the sixteen governments negotiating the Regional Comprehensive Economic Partnership (RCEP)
17-Oct-2016
95 health, community and development organisations in the Asia Pacific region call on trade negotiators from sixteen countries in the Regional Comprehensive Economic Partnership agreement negotiations to ensure access to medicines is protected. We the undersigned organisations call on negotiators to protect health and reject all TRIPS plus intellectual property measures in the RCEP.
Open letter to ambassadors (in India) of RCEP negotiating countries by Delhi Network of Positive People
13-Oct-2016 Don’t trade our lives away
Member countries must consider the impact of RCEP on access to medicines in developing countries
The Aids revolution is why Asean, India and China must resist controls on generic drugs
11-Oct-2016 South China Morning Post
Affordable generics have transformed medical treatment, yet intellectual property provisions in a China-led regional trade deal could block access to life-saving drugs for millions in Africa and Asia
In boon for Big Pharma, TTIP would lock in high drug prices: report
5-Oct-2016 Common Dreams
’Unfortunately, trade agreements have become one more mechanism for drug corporations to expand their monopoly power’
Big Pharma lobbying in TTIP: Bad news for patients
28-Sep-2016 Corporate Europe Observatory
Big Pharma is everything but shy when it comes to lobbying EU policy-makers. But what exactly are these groups lobbying for in TTIP?
US pressures Australia for stronger TPP biologics monopolies
12-Sep-2016 Scoop
According to the Bloomberg, Senator Hatch said “They’re going to have to find a way of having the countries agree to change that formality in the TPP to 12 years…If Australia wants to be part of it, they have to meet our terms,”
Call to remove IP clauses from trade pact
15-Aug-2016 The Hindu
As the next round of Regional Comprehensive Economic Partnership (RCEP) trade talks begin in Vietnam, humanitarian aid organisation Médecins Sans Frontières calls for the removal of intellectual property provisions from the agreement
Clause for evergreening of patents dropped from RCEP: Nirmala
8-Aug-2016 PTI
Provisions related to evergreening of patents in the proposed Regional Comprehensive Economic Partnership Agreement (RCEP) was dropped after stiff opposition from India, Parliament was informed today.
TPP heightens urgency for national drug coverage in Canada
6-Jul-2016
Adopting a national pharmacare program would offset the higher drug prices expected with the ratification of the Trans-Pacific Partnership, write Tanishq Suryavanshi and Jake Hirsch-Allen.
Civil society letter to countries negotiating Regional Comprehensive Economic Partnership (RCEP)
13-Jun-2016 TWN
We call on countries negotiating the RCEP agreement and to protect the flexibilities available under the WTO TRIPS agreement for Least Developed Countries (LDCs).
At landmark BRICS meet, India raises public health, pharma sector concerns
25-May-2016 First Post
A high-level panel hosted by India discusses the issues of trade deals that inhibit access to medicines and also limit policy space for governments to legislate in public interest.
Standing up to patent bullying
25-May-2016 The Hindu
The Ministry of Commerce must be cautious of Free Trade Agreements being negotiated with the European Union as well as the Regional Comprehensive Economic Partnership that further strengthen or extend intellectual property (IP) monopolies.
Is India holding the line against another TPP?
20-May-2016 East Asia Forum
Of the RCEP negotiating countries, it is India, rather than China, that has been the most outspoken in opposing US-style trade rules.
Letter from Colombian Embassy regarding Senate Finance, USTR pressure on Novartis compulsory license
12-May-2016 KEI
The letter says that this dispute over the compulsory license could prejudice resources for a new initiative called "Paz Colombia", as well as the US FTA with Colombia, and access to the TPP.
New threat against affordable medicines in trade negotiations with India and ASEAN
21-Apr-2016 MSF
Access to affordable medicines could be severely restricted for millions of people around the world under the current proposals in the Regional Comprehensive Economic Partnership (RCEP) trade agreement?
Peru – The TPP quandary and access to medicines
14-Apr-2016 El Comercio
Signing the TPP has provoked a debate on whether, when it comes into force, there will be a potential spike in medicines prices.
Mercosur and Unasur establish a platform for the joint purchase of medicines
14-Apr-2016 Nodal
The historic decision to break barriers to improve access to costly medicines was taken during the “First Extraordinary Meeting of the Ministers of the Common Market of the South (Mercosur).
It’s not just Europeans who will feel the consequences of TTIP
5-Apr-2016 New Statesman
One element of TTIP has been largely ignored – the deal’s impact on developing countries.